SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-006713
Filing Date
2017-03-07
Accepted
2017-03-07 17:45:36
Documents
1
Period of Report
2017-03-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3996
  Complete submission text file 0000899243-17-006713.txt   5540
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Issuer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 131 HARTWELL AVE LEXINGTON MA 02421
Business Address
Clark David J (Reporting) CIK: 0001662693 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36332 | Film No.: 17673181